Bioassay-guided fractionation of the organic extract from the marine sponge Acanthella costata resulted in the isolation of the known natural product, (-)-dibromophakellin (1). Using a fluorescence imaging plate reader (FLIPR) based assay, compound 1 was identified as displaying agonist activity against the α 2B adrenoceptor, with an EC 50 of 4.2 M. Debromination and SuzukiMiyaura coupling reactions were undertaken in order to provide structure activity data about the pyrrole ring of this marine metabolite. These synthetic studies generated the known natural product analogues, (-)-phakellin (2), and (-)-monobromophakellin (3), along with the new synthetic derivatives (-)-4-bromo-5-phenylphakellin (5) and (-)-4,5-diphenylphakellin (6). Substitution of the C-5 Br of 1 with H (2 and 3) or phenyl (5 and 6) resulted in loss of activity indicating that Br at C-5 is required for agonist activity.
Introduction
The 2 -adrenoceptors ( 2 -ARs) are members of the G-protein coupled receptor (GPCR) superfamily and respond to the physiological agonists noradrenaline and adrenaline. The 2 -ARs are widely distributed throughout the body and are located in both the CNS and peripheral tissue.
The receptors are located both presynaptically and postsynaptically.
1,2 Central effects of 2 -ARs include analgesia, sedation, hypotension, regulation of hypothermia, gastric protection and gastric motility. In the periphery they are present in smooth muscle and are involved in venous contraction. 1,2 Through receptor binding and molecular cloning studies, three subtypes have been identified, 2A , 2B and 2C . A fourth subtype, the 2D has been found in the rat and is thought to be the species orthologue of the human 2A . 3 A number of non-selective 2 agonists have been used clinically for antihypertensive treatment, pain control and as anesthetic adjuncts. 4, 5 The hypotensive and sedative effects caused by these agonists have been found to be mediated through the 2A subtype. These are however unwanted side effects for potential new clinical applications of the other receptor subtypes. The discovery of a compound with selective agonist activity for these subtypes may provide a useful lead in the development of new drug therapies in areas such as gastric protection and post anesthetic care. 5 From HTS of a library containing 61 674 crude biota extracts we discovered that the organic extract from the marine sponge Acanthella costata (Axinellidae) showed micromolar activity in an α 2B adrenoceptor FLIPR assay. Bioassay-guided fractionation of the crude organic extract resulted in the isolation of the previously reported natural product, (-)-dibromophakellin (1), 6 which was subsequently shown to account for the activity displayed in the crude organic extract (Figure 1 ).
Herein we report the isolation and α 2B adrenoceptor agonist activity of (-)-dibromophakellin (1), along with several synthetic studies aimed at providing structure activity about the pyrrole ring of this bioactive lead molecule.
Results and discussion
A freeze-dried and ground sample of A. costata was extracted with DCM and MeOH. The resulting organic extracts were combined and chromatographed using C 18 bonded silica HPLC to yield (-)-dibromophakellin (1, 57.6 mg, 0.576% dry wt).
The TFA salt of (-)-dibromophakellin (1) was isolated as an optically active stable gum. were undertaken in order to provide some structure activity data about the pyrrole ring of 1.
Dehalogenation of (-)-dibromophakellin was performed under catalytic hydrogen transfer conditions using HCO 2 NH 4 and Pd/C in MeOH. 7 Purification of the reaction mixture by C 18 bonded silica HPLC afforded the TFA salt of the previously reported natural product derivative, (-)-phakellin (2, 3.5 mg, 35%). 6 The structure of 2 was identified following comparison of spectroscopic data with literature values. 6 (-)-Phakellin (2) showed no agonist activity when screened at concentrations up to 83 M in the α 2B adrenoceptor FLIPR assay. These data suggested that the lipophilic nature of either one or both bromine atoms in 1 was essential for α 2B
adrenoceptor agonist activity; hence we decided to see whether we could replace either or both bromine atoms with a lipophilic aryl substituent. A review outlining palladium catalyzed crosscoupling reactions involving pyrroles has been published 8 and Suzuki-Miyaura couplings 9 were chosen for these synthetic manipulations due to the simplicity and ease of this reaction type.
Regioselective cross-couplings between 4,5-di or 3,4,5-tribrominated pyrrole moieties and aryl boronic acids have been reported in the literature to occur preferentially at the C-5 position. 10, 11 Also, monoarylation of 4,5-dibrominated pyrroles has been reported to take place adjacent to the ring nitrogen in Negishi-type cross couplings with zincated species. 12 The Suzuki-Miyaura crosscoupling reaction was initially attempted with 1 and phenyl boronic acid, using Cs 2 CO 3 in the presence of Pd(OAc) 2 and PPh 3 , in xylene:EtOH:H 2 O (5:1:1) at reflux overnight. 10 The reaction Miyaura coupling reactions is not unexpected 13, 14 and has been observed to occur significantly at C-4 for 4-bromo-and 4,5-dibromopyrrole-2-carboxylates. 15 This side reaction can be suppressed by the use of a Boc protecting group on the pyrrole nitrogen, which serves to reduce the electron density of the pyrrole. 15, 16, 17 These results prompted us to try the coupling reactions after Boc protection of the guanidine in 1. 18 This protection was performed under standard conditions of Boc 2 O in DCM (Scheme 1). 19 Following rapid silica flash chromatography of the reaction mixture,
we obtained a mixture of the mono-, di-and tri-Boc protected products 18 (4), which was used immediately for the Suzuki-Miyaura coupling. The mixture 4 was treated with phenyl boronic acid, and Na 2 CO 3 in the presence of Pd(OAc) 2 and PPh 3 in DME/H 2 O at reflux overnight. MS analysis of the crude reaction mixture indicated the presence of both mono-(5) and diphenylated (6) products. Chromatography using C 18 bonded silica HPLC yielded the TFA salt of the new natural product analogues, (-)-4-bromo-5-phenylphakellin (5, 6.0 mg, 6%) and (-)-4,5-diphenylphakellin (6, 2.1 mg, 2%). This reaction was not optimized. The structures of both of these compounds were elucidated following 1D/2D NMR and HRMS data analysis. Since C-5 of the pyrrole system in 1 is more electron deficient, 10, 20 it was predicted that 5-Br would be the first position for the SuzukiMiyaura coupling to take place and hence the formation of the monophenyl analogue (5) was not unexpected. A strong ROESY correlation between H-6 and H-17 and H-21 confirmed that the phenyl ring of 5 was indeed substituted at C-5. Diarylated products resulting from Suzuki-Miyaura cross-coupling reactions of 4,5-dibrominated pyrroles using similar reaction conditions have also been reported.
11,12
Compounds 3, 5 and 6 were subsequently tested in the α 2B adrenoceptor FLIPR assay.
Surprisingly none of these analogues showed any activity when screened up to 83 M. Isosteric replacement of the C-5 Br with a Cl, CF 3 or CH 3 substituent may have proven more successful, however due to lack of material other synthetic manipulations could not be pursued. In conclusion, substitution of the C-5 Br of 1 with H (2 and 3) or phenyl (5 and 6) resulted in loss of α 2B
adrenoceptor agonist activity. These data indicated the importance of Br at C-5 for this receptor.
Conclusion
Bioassay-guided fractionation of the organic extract from the marine sponge A. costata identified (-)-dibromophakellin (1) as an α 2B adrenoceptor agonist, with an EC 50 of 4.2 M. A series of small-scale synthetic reactions were performed on this marine natural product in order to provide structure activity data about the pyrrole ring. These synthetic studies identified that the substitution of the C-5 Br of 1 with H or phenyl resulted in loss of activity, indicating that Br at C-5
is required for α 2B adrenoceptor agonist activity.
Experimental

General methods
Optical rotations were recorded on a Jasco P-1020 polarimeter. UV and IR spectra were recorded on a Camspec M501 spectrophotometer and a Bruker Tensor 27 spectrometer, respectively. NMR spectra were recorded at 30 o C on either a Varian 500 MHz Unity INOVA or 600 MHz NMR system spectrometer. The latter spectrometer was equipped with a triple resonance cold probe. 
Biological material
A. costata was collected by scuba diving (-25 m) at Sykes Reef (Capricorn-Bunker Group Great
Barrier Reef) during August 1996, and kept frozen prior to freeze-drying and extraction. Voucher specimen G307233 has been deposited at the Queensland Museum, South Brisbane, Queensland, Australia.
Extraction and isolation
A freeze-dried and ground sample of A. costata (10 g) was exhaustively extracted with DCM (1 L) and MeOH (1 L). Both extracts were combined and evaporated to yield a brown gum (1.5 g) that was preadsorbed to C 18 (5 g) then packed into a stainless steel cartridge (25 × 50 mm). The cartridge was attached to a C 18 HPLC column and a linear gradient from H 2 O (1% TFA) to MeOH (1% TFA) at a flowrate of 9 mL/min over 35 min was run. One min fractions were collected from time = 0 min; fraction 14 contained the TFA salt of (-)-dibromophakellin (1, 57.6 mg, 0.576% dry wt).
TFA salt of (-)-dibromophakellin (1).
Light brown gum; identified by comparison with literature data. 
Debromination of (-)-dibromophakellin (1)
To an Ar purged solution of 1 (16.0 mg, 43 mol) in MeOH (2.0 mL) was added HCO 2 NH 4 (38.0 mg, 603 mol) and 10% Pd/C (30.0 mg), and the mixture was stirred under Ar at rt for 24 h. 7 The reaction solution was filtered through an SPE cartridge packed with diatomaceous earth and the column washed with 100% MeOH (10 mL). The MeOH eluent was preadsorbed to C 18
(1 g) then packed into a stainless steel cartridge (10 × 30 mm). The cartridge was attached to a C 18 HPLC column and a linear gradient from H 2 O (1% TFA) to MeOH (1% TFA) at a flowrate of 9 mL/min over 59 min was run. One min fractions were collected from time = 0 min; fractions 18 and 19 contained the TFA salt of (-)-phakellin (2, 3.5 mg, 35%).
TFA salt of (-)-phakellin (2). Colorless gum; identified by comparison with literature
data. 
Suzuki-Miyaura coupling reaction 1 (no Boc protection of 1)
Using conditions similar to that described by Schröter and Bach, 10 to a suspension of (-)- 
Suzuki-Miyaura coupling reaction 2 (Boc protection of 1)
In a Wheaton vial (5 mL), Pd(OAc) 2 (4.2 mg, 0.019 mmol) was added to a suspension of Boc 
